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Abstract 
Objective: As a widely used instrument for patients with extremity sarcoma, the Toronto Extremity Salvage Score 
(TESS) has never been cross-culturally adapted for Chinese population. The objective of our study was to investigate 
the comprehensibility, reliability and validity of the Chinese version of TESS for use in patients with extremity sarcoma.
Methods: A consensus version of the Chinese TESS was developed under the review of a committee according to 
international guidelines. 64 patients were recruited to complete the Chinese TESS, the Musculoskeletal Tumor Society 
(MSTS) Rating Scale, and the Quality of Life Questionnaire Core 30 (QLQ-C30). Reliability was assessed using the 
intra-class correlation coefficient (ICC) and Cronbach’s α. Validity was assessed with Pearson’s correlation between the 
similar domains of the two questionnaires.
Results: The ICCs for the test–retest reliability was 0.932 for the upper extremity questionnaire and 0.893 for lower 
extremity questionnaire, respectively. The Cronbach’s α was 0.953 for the lower extremity questionnaire and 0.921 for 
the upper extremity questionnaire, respectively. Convergent validity of the TESS based on Pearson correlation coef-
ficients indicated significantly moderate to high correlations between the TESS and the MSTS as well as the QLQ-C30, 
with r ranging from 0.535 to 0.782.
Conclusions: The Chinese TESS is a comprehensible, reliable, and valid instrument that can be utilized for future 
cross-cultural international studies of extremity sarcoma.
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Background
Sarcoma is a rare type of cancer that represents approxi-
mately 1 % of all newly diagnosed cancers (Borden et al. 
2003). Due to the significant impact of extremity sarcoma 
surgery on the patients’ function, health related qual-
ity of life (HRQoL) is now recognized as an important 
outcome measure of the surgery (Hoffmann et  al. 2006; 
Griesser et al. 2012; Ruggieri et al. 2011). Development of 
instruments to measure HRQoL is essential to determine 
patients’ perceived physical and mental health (Schreiber 
et  al. 2006; Lopez-Guerra et  al. 2011). To be noted, 
patients with sarcoma may have a significant heterogene-
ity regarding tumor type, reconstructive techniques and 
the extent of tissue excised during surgery. Therefore, it is 
important to develop an instrument that takes heteroge-
neity into account when measuring functional outcome. 
And a disease-specific measure rather than a generic 
measure is preferred for the proper assessment of physi-
cal function in patients with extremity sarcoma.
To date, several disease-specific questionnaires have 
already been developed to evaluate functional outcomes 
for patients undergoing surgery for extremity sarcomas 
(Davis et al. 1996; Enneking et al. 1993; Bekkering et al. 
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2009). Some examiner-dependent clinical measures such 
as range of motion and muscle strength or a combina-
tion of symptoms and mobility have been used. However, 
measures that reflect the patient’s perception seems more 
desirable in clinical practice. As a patient-completed 
questionnaire that takes into account the heterogeneity 
of sarcomas, the Toronto Extremity Salvage Score (TESS) 
was developed for assessing physical function of patients 
undergoing surgery for extremity sarcoma (Davis et  al. 
1996).
The TESS questionnaire is a disease-specific and self-
administered questionnaire based on the definitions of 
disability, impairment, and handicap as documented by 
the World Health Organization (Davis et  al. 1996). The 
content of the TESS includes the types of functional dif-
ficulties experienced by extremity sarcoma patients, such 
as body movement, mobility, self-care, and performing 
daily tasks. To date, several studies have reported the val-
idation of the TESS in a Portuguese (Saraiva et al. 2008), 
Danish (Saebye et al. 2014), Korean (Kim et al. 2015) and 
Japanese version (Ogura et al. 2015), yielding good test–
retest reliability and internal consistency. However, to the 
best of our knowledge, there is no study that addresses 
the application of TESS to patients from the Chinese 
population. Herein, this study was conducted to investi-
gate the comprehensibility, reliability and validity of the 




The protocol of recruitment of participants was approved 
by the ethics committee of the hospital. Patients who vis-
ited our clinic center between March 2011 and Septem-
ber 2014 were prospectively evaluated for the eligibility 
of recruitment in this study. The following inclusion cri-
teria were used: (1) aged more than 18 years; (2) at least 
1 year after curative surgery for histologically confirmed 
extremity sarcoma; (3) without local recurrence, distant 
metastasis or complications related to surgery. Finally, 64 
patients including 35 male and 29 female participated in 
the study and gave their informed consent. Demographic 
data were collected from the medical records, including 
patients’ age, gender, location of the tumor, histological 
type, type of surgery and period of follow-up.
Translation and adaptation of the TESS
The translation and adaptation processes of the TESS 
were performed according to the guidelines used by 
previous literatures (Saraiva et al. 2008; Kim et al. 2015; 
Ogura et al. 2015). The English version of the TESS was 
translated into Chinese independently by three native 
Chinese bilingual translators who were familiar with the 
topic and the research concept. Subsequently, the two 
translators with the medical background analyzed and 
compared the three translations together with two sen-
ior musculoskeletal oncologists, and then combined 
them into one single translation. The consensus ver-
sion was back translated into English independently 
by two bilingual translators who were kept blind to the 
procedures of the forward translation. All versions of 
the translation were analyzed by the expert committee, 
which was comprised of the 5 translators, one method-
ologist, and 2 orthopedic surgeons (X.L. and W.S.). The 
committee evaluated conceptual equivalence of all items 
and answers, and discrepancies between members were 
discussed. The pre-final version of the TESS was created 
after consensus was reached among the expert commit-
tee. In the pre-test step, 40 volunteers aged more than 
18 years were recruited from the local community to test 
the pre-final Chinese version of the TESS. These volun-
teers were questioned about their understanding of the 
questionnaire items. Most of the items in the question-
naire could be correctly understood and answered by the 
volunteers. There was a high incidence of “not applica-
ble” with regard to the question on sexual activity, which 
was therefore omitted from the questionnaire. After this 
process, the final version of the Chinese version of the 
TESS was developed. It consists of a lower extremity and 
an upper extremity version both with 29 questions. Each 
question is rated on 5-point scale, including “impossible 
to do,” “extremely difficult,” “moderately difficult,” “a little 
bit difficult,” and “not at all difficult”. The participant can 
select “not applicable” when the question is not a usual 
activity. The total score ranges from 0 to 100, with higher 
scores indicating better function.
Reliability and validity test of the TESS
All the patients were asked to answer the TESS ques-
tionnaire at their follow-up visit after surgery. The time 
needed for the completion of the questionnaire was 
recorded for each participant. To examine the test–
retest reliability, patients were asked to complete the 
same TESS questionnaire 1  week later. All the patients 
returned the second questionnaire used for analysis. The 
data were collected by an author (S.W.) who was kept 
blind of the patients’ diagnosis or treatment.
To examine the convergent validity, the patients were 
also asked to complete the Musculoskeletal Tumor Soci-
ety (MSTS) Rating Scale, and the Quality of Life Ques-
tionnaire Core 30 of European Organization for Research 
and Treatment of Cancer (EORTC QLQ-C30). The MSTS 
Rating Scale is a widely used functional score for patients 
with extremity sarcoma (Rebolledo et al. 2013). It consists 
of factors pertinent to the patient, including pain, func-
tion, emotional acceptance, use of any external support, 
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walking ability, and gait alteration. A value of 0–5 points 
(maximum overall score, 30 points) was assigned to each 
of these factors. The QLQ-C30 is a 30-item questionnaire 
used to evaluate the function and QoL in cancer patients 
(Fitzsimmons et al. 1999). The following scales among the 
functional scales of QLQ-C30 were used in this study, 
including physical functioning (PF), role functioning 
(RF), social functioning (SF) and QoL. A high score on 
the functional scales represents a high level of QoL and a 
high level of functionality.
Factor analysis
Confirmatory factor analysis was carried out with each 
factor being specified to load on its subscale. Model fit 
was assessed with the following parameters, including the 
comparative fit index (CFI), the normed fit index (NFI), 
root-mean square error of approximation (RMSEA), and 
the 90  % confidence intervals (CIs) of RMSEA. A good 
fit of the model was indicated by ratios between the Chi 
square test and degrees of freedom less than 3, CFI and 
NFI values not less than 0.90, and RMSEA not more than 
0.08.
Statistical analysis
SPSS for Windows version 16.0 statistical software (SPSS, 
Chicago, IL, USA) was used for statistical analyses. 
Descriptive demographic data and scores were reported 
as mean values ± standard deviation. The test–retest reli-
ability was examined using intra-class correlation coef-
ficient (ICC). The internal consistency was evaluated by 
Cronbach’s α, with a value >0.70 considered acceptable. 
To determine the convergent validity of the TESS, cor-
relations between similar domains of the TESS and the 
QLQ-C30 or the MSTS were analyzed by Pearson cor-
relation analysis. The correlation coefficient larger than 
0.40 was considered to indicate adequate convergent 
validity.
Results
The mean time used to complete the TESS question-
naire was 285.2  ±  75.7  s (range 182–382). The base-
line characteristics of the patients were summarized in 
Table 1. The mean age at the time of completion of the 
questionnaire was 47.5 ± 15.2 years (range 18–68 years). 
The most common histological types were osteosarcoma 
(n = 15) and chondrosarcoma (n = 13) for bone sarcoma 
and liposarcoma (n =  11) for soft tissue sarcoma. Most 
patients received limb salvage surgery followed by chem-
otherapy with a mean follow-up of 1.9 ± 1.2 years (range 
1–3 years).
Results of reliability evaluation for Chinese version of 
the TESS were summarized in Table 2. The ICC for the 
test–retest reliability was 0.932 for the upper extremity 
questionnaires (95  % confidence interval (CI) =  0.745–
0.971) and 0.893 for lower extremity questionnaires 
(95 %CI = 0.755–0.937), respectively. In addition, the test 
for internal consistency showed strong reliability with a 
Cronbach’s α of 0.953 for the lower extremity question-
naire and 0.921 for the upper extremity questionnaire. 
The Pearson correlation coefficients between one item 
and the total score ranged from 0.533 to 0.869 for the 
lower extremity questionnaire and from 0.587 to 0.913 
for the upper extremity questionnaire.
As shown in Table 3, the overall mean score of the TESS 
was 87.6 ± 20.2 (range 40–100). The mean scores of the 
lower extremity questionnaire and the upper extremity 
questionnaire were 83.4 (range 40–100) and 92.3 (range 
45–100), respectively. The mean score of the MSTS was 
24.6 (range 5–30). The mean score of the QLQ-C30 was 
Table 1 Baseline characteristics of the patients
Characteristic Patients (n = 64)




Time from surgery (year) 1.9 ± 1.2
Tumor location
Upper extremity
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78.1 (range 0–100) for PF, 67.5 (range 0–100) for RF, 71.2 
(range 0–100) for SF and 68.2 (range 0–100) for QoL, 
respectively.
Convergent validity of the TESS based on the com-
parison with the MSTS and the QLQ-C30 was shown in 
Table 4. Pearson correlation coefficients indicated signifi-
cantly moderate to high correlations between the TESS 
and the MSTS or the 4 scales of QLQ-C30, with r rang-
ing from 0.532 to 0.782. The strong correlations were 
observed between the TESS and the PF scale of QLQ-
C30. Table 5 shows the results of the factorial analysis of 
the TESS. According to the pre-established thresholds of 
RMSEA, NFI and CFI, the 2-factor model met the crite-
ria for a good fit.
Discussion
The original TESS questionnaire was a valid, reliable 
and sensitive self-reported instrument to evaluate the 
functional outcome of sarcoma patients. To date, differ-
ent language versions of the TESS have been validated 
in Western and Asian populations (Davis et  al. 1996; 
Saraiva et  al. 2008; Saebye et  al. 2014; Kim et  al. 2015; 
Ogura et  al. 2015). For the first time, this study sought 
to validate the cross-culturally adapted Chinese ver-
sion of the TESS. During our translation of the TESS 
into Chinese, cross-cultural bias was taken into account 
according to the guidelines reported by Guillemin et  al. 
(Guillemin et al. 1993). A few cultural discrepancies were 
encountered and some items of the TESS were there-
fore modified accordingly. The question on sexual activ-
ity was omitted from the questionnaire due to the high 
incidence of “not applicable”. Comparably, there was 
also a high rate of “not applicable” regarding the ques-
tion on sexual activity in the Korean and Japanese ver-
sion of the TESS (Kim et al. 2015; Ogura et al. 2015). We 
believed that it might be attributed to the different cul-
tural background between the Asian and Western popu-
lations. Besides, “cutting food while eating” was replaced 
by “using chopsticks when eating” as the majority of the 
Chinese use chopsticks at meals instead of a knife and 
fork. After translation and cross-cultural adaptation, the 
mean completion time of the TESS was short and com-
parable with results reported by other studies. Therefore, 
we confirmed that the Chinese version of the TESS could 
be clearly understood and easily administered to the 
patients.
Compared with other language versions of the TESS, 
the Chinese TESS showed similar test–retest reliability, 
internal consistency and validity. The ICCs of 0.93 for 
the upper extremity questionnaire and 0.89 for the lower 
extremity questionnaire demonstrated a high level of 
reliability. Comparably, Saebye et al. (2014) reported the 
ICC for the upper and lower extremity questionnaires 
in the Danish population were 0.96 and 0.88 (95  % CI 
0.697–0.956), respectively. In a recent study performed 
in the Korean population, Kim et  al. (2015) reported 
ICCs of 0.979 for the upper extremity TESS and 0.874 
for the lower extremity TESS respectively. In our study, 
Table 2 Reliability test of  the simplified Chinese version 
of the TESS
a ICC indicates Intraclass correlation coefficient; 95 % CI indicates 95 % 
confidential interval
b Correlations between one item and the total score excluding that item using 
Spearman rank correlation coefficient
The TESS ICC (95 % CI)a Cronbach’s α Correlationb
Lower extremity 0.893 (0.755–0.937) 0.953 0.533–0.869
Upper extremity 0.932 (0.745–0.971) 0.921 0.587–0.913
Table 3 Patients’ score of the TESS, the MSTS and the QLQ-
C30
a TESS indicates Toronto Extremity Salvage Score
b MSTS indicates Musculoskeletal Tumor Society
c QLQ-C30 indicates Quality of Life Questionnaire Core 30
Lower extremity Upper extremity
(n = 41) (n = 23)
TESSa 83.4 ± 19.5 92.3 ± 22.7
MSTSb 25.5 ± 6.5 23.1 ± 4.3
QLQ-C30c
 Physical functioning 77.4 ± 25.3 78.9 ± 18.4
 Role functioning 66.3 ± 23.2 68.2 ± 21.5
 Social functioning 72.1 ± 15.6 70.8 ± 20.3
 Quality of life 69.3 ± 24.1 66.4 ± 26.2
Table 4 Convergent validity of the Chinese TESS
† p < 0.05
Lower extremity (r) Upper extremity (r)
MSTS 0.637† 0.682†
QLQ-C30
 Physical functioning 0.782† 0.735†
 Role functioning 0.638† 0.547†
 Social functioning 0.712† 0.532†
 Quality of life 0.689† 0.635†
Table 5 Factor analysis of the Chinese TESS
χ2/df ratio between the Chi square test and degrees of freedom, CFI comparative 
fit index, NFI normed fit index, RMSEA root-mean square error of approximation, 
CI confidence interval
Model χ2/df CFI NFI RMSEA 90 % CI
2-Factor model 1.79 0.92 0.91 0.068 0.056–0.079
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Cronbach’s α value for internal consistency was 0.953 
and 0.921 for the lower and the upper extremity ques-
tionnaire, respectively. Similarly, the internal consist-
ency of the lower and the upper extremity questionnaire 
reported in previously studies was 0.90 and 0.94 in Den-
mark and 0.978 and 0.989 in Korea (Saebye et  al. 2014; 
Kim et  al. 2015). To investigate the convergent validity, 
comparisons were made among the TESS, the MSTS and 
the functional part of the QLQ-C30. We chose the MSTS 
and QLQ-C30 as they are reliable questionnaires devel-
oped for cancer patients. Our results showed that there 
were good correlations between the TESS and the MSTS 
and between the TESS and the QLQ-C30. The Pearson 
correlation coefficients indicated significantly moderate 
to high correlations between the TESS and the other two 
questionnaires. Collectively, we believed that the current 
Chinese version of the TESS questionnaire could well 
maintain the properties of the original version to meas-
ure the QoL of sarcoma patients.
The TESS validation study reported here reflects the ris-
ing importance of expanding our knowledge on the physical 
function of extremity sarcoma patients. As indicated by the 
good correlation with the PF scale of QLQ-C30, the TESS 
can specifically evaluate variable levels of physical func-
tion. However, other important domains of QoL, includ-
ing body image, mental status and social activities were not 
taken into account when applying the TESS to patients with 
musculoskeletal tumors. Design of such a disease-specific 
instrument that can evaluate HRQOL for patients with 
musculoskeletal tumors comprehensively is awaited.
Several limitations still exist in the current study. First, 
the present study did not test the ability of the TESS to 
detect the responsiveness of patients to the treatment, 
which was limited mainly by a relatively small number 
of patients. A larger sample size is therefore recom-
mended for to clarify this result in future studies. Sec-
ond, we did not investigate the relationship between the 
TESS scores and time from surgery or type of surgery. 
Herein, further investigation into the sensitivity of the 
TESS to detect the HRQOL in patients with different 
time from surgery or undergoing different types of sur-
gery was warranted.
In conclusion, we have translated the TESS question-
naire into Chinese and validated the questionnaire. Our 
results showed that Chinese version of the TESS is a 
comprehensible, reliable, and valid instrument and can 
be utilized for future cross-cultural international studies 
of extremity sarcoma.
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